StockData
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW) stock

TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.23−0.03 (-10.27%)

Close on Nov 17, 2026Market cap $3.59MP/E –Yield –

Earnings

Traws Pharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 12, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q2 FY2026
–
– on a year earlier
EPS, Q2 FY2026
-$0.16
-$0.11 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Traws Pharma's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 12, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 14, 2026after the close––-$0.16Release
Q1 FY2026ended Mar 31, 2026May 15, 2026before the open$0-100.0%-$0.53Release
Q4 FY2025ended Dec 31, 2025Apr 15, 2026after the close–––Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025before the open––-$0.34Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open$2.70M–-$0.11Release
Q1 FY2025ended Mar 31, 2025May 15, 2025before the open$57.00K+1.8%$2.09Release
Q4 FY2024ended Dec 31, 2024Mar 31, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 14, 2024after the close$57.00K0.0%-$8.81Release
Q2 FY2024ended Jun 30, 2024Aug 15, 2024before the open–––Release
Q1 FY2024ended Mar 31, 2024May 16, 2024after the close$56.00K0.0%-$0.24Release
Q3 FY2023ended Sep 30, 2023Nov 14, 2023after the close$57.00K0.0%-$0.23Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Traws Pharma has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Traws Pharma puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Traws Pharma filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Results
  4. Update
  5. Update
  6. Update
  7. Results
  8. Results
  9. News
  10. News
  11. News
  12. News
  13. News
  14. Results
  15. Results

See a number that looks wrong?